China Looks At Innovation, Quality Policies As Chronic Diseases Rise
This article was originally published in The Pink Sheet Daily
Maximizing innovation and focusing on product quality should be prioritized in China’s next Five-Year Plan for the pharma industry, representatives proposed at a recent government meeting. Meanwhile, data from the national health regulator have indicated a sharp rise in chronic diseases and obesity in the country.
Register for our free email digests: